Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

Pragya Dhruv YadavRima R SahayGajanan SapkalDimpal NyayanitAnita M SheteGururaj DeshpandeDeepak Y PatilNivedita GuptaSanjay KumarPriya AbrahamSamiran PandaBalram Bhargava

Published in: Journal of travel medicine (2021)

Sera of COVID-19 naive vaccinees, COVID-19 recovered cases with vaccination and breakthrough cases demonstrated 1.3, 2.5 and 1.9-fold reduction in neutralization titers against Delta and 1.5, 3.5, 2.8-fold against Delta AY.1 compared to B.1 respectively. However, high neutralization titers would still effectively protect against Delta, Delta AY.1 and B.1.617.3 variants.

Keyphrases

sars cov
coronavirus disease
gene expression
hiv infected
dna methylation